[Protective effects of beraprost plus simvastatin on monocrotaline-induced pulmonary arterial hypertension in rats].

Shenghao Wang, Shuang Liu, Jinghua Yang, Zengzhi Wang, Jie Li, Weiwei HouPubMed 2013

Abstract

The combined use of beraprost and simvastatin may delay the increase of mPAP and remodeling of pulmonary vessels and inhibit right ventricular hypertrophy in pulmonary arterial hypertension rats. Its efficacy is superior to that of monotherapy.
BibTeX
@inproceedings{wang2013protective,
  author = {Shenghao Wang and Shuang Liu and Jinghua Yang and Zengzhi Wang and Jie Li and Weiwei Hou},
  title = {{[Protective effects of beraprost plus simvastatin on monocrotaline-induced pulmonary arterial hypertension in rats].}},
  booktitle = {PubMed},
  year = {2013},
}

Loading related content...

Figure